What 7 Analyst Ratings Have To Say About Staar Surgical
Portfolio Pulse from Benzinga Insights
Analyst ratings for Staar Surgical (NASDAQ:STAA) show a mix of bullish and indifferent sentiments, with 5 bullish and 2 indifferent ratings recently. The average 12-month price target for STAA has risen to $47.43, up 10.66% from the previous $42.86, with a high estimate of $55.00 and a low of $33.00. Staar Surgical's financial performance includes a 19.09% revenue growth rate, a net margin of 10.17%, an ROE of 2.03%, an ROA of 1.62%, and a low debt-to-equity ratio of 0.09, indicating strong profitability and effective asset and equity utilization.
May 08, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical's analyst ratings range from bullish to indifferent, with an increased average price target. The company's financials show significant growth and profitability.
The positive analyst ratings and raised price target reflect optimism about Staar Surgical's future performance. The company's strong financial metrics, such as high revenue growth, net margin, ROE, and ROA, alongside a low debt-to-equity ratio, suggest a robust financial health and operational efficiency, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100